The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial.

Simon ParlowPietro Di SantoRebecca MathewRichard G JungTrevor SimardTaylor GillmoreBrennan MaoOmar Abdel-RazekF Daniel RamirezJeffrey A MarbachAlexander DickChristopher GloverJuan J RussoMichael FroeschlMarino LabinazShannon M FernandoBenjamin Hibbertnull null

Published in: European heart journal. Acute cardiovascular care (2021)

In patients with CS treated with inotrope therapy, low MAP is associated with worse clinical outcomes. Randomized data evaluating optimal MAP targets in CS is needed to guide medical therapy.

Keyphrases

phase iii
phase ii
open label
double blind
study protocol
electronic health record
high density
machine learning
randomized controlled trial
bone marrow
mesenchymal stem cells
placebo controlled
big data
stem cells
cell therapy
artificial intelligence
smoking cessation